Alimera Sciences, Inc.

ALIM | NASDAQ | 0 Sledující

$5.54

-0.18%

-$0.01

Sledovat

Overview Metrics Financials

Breakdown	12/31/2023 USD	12/31/2022 USD	12/31/2021 USD
Total revenue	80,754 +49.19%	54,129 -8.30%	59,029 -
Cost of revenue	19,584 +145.51%	7,977 +13.47%	7,030 -
Gross profit	61,170 +32.54%	46,152 -11.24%	51,999 -
Operating expense	62,641 +8.39%	57,792 +10.71%	52,200 -
Operating income	-1,471 +87.36%	-11,640 -5,691.04%	-201 -
Pretax Income	-20,047 -10.89%	-18,079 -359.56%	-3,934 -
Tax Provision	85 +203.57%	28 -93.61%	438 -
Net income	-20,132 -11.18%	-18,107 -314.16%	-4,372 -
EPS	-0.79 +69.50%	-2.59 -292.42%	-0.66 -
Diluted EPS	-0.79 +69.50%	-2.59 -292.42%	-0.66 -
Average Shares	25,562 +265.33%	6,997 +6.09%	6,595 -
Diluted Average Shares	25,562 +265.33%	6,997 +6.09%	6,595 -
EBIT	-9,862 +19.15%	-12,198 -924.75%	1,479 -
EBITDA	7,276 +181.44%	-8,934 -475.69%	2,378 -

Soubory cookie používáme ke zlepšení prohlížení na webu.